152 related articles for article (PubMed ID: 29651441)
21. A short-term in vivo model for giant cell tumor of bone.
Balke M; Neumann A; Szuhai K; Agelopoulos K; August C; Gosheger G; Hogendoorn PC; Athanasou N; Buerger H; Hagedorn M
BMC Cancer; 2011 Jun; 11():241. PubMed ID: 21668953
[TBL] [Abstract][Full Text] [Related]
22. Differential expression of filamin B splice variants in giant cell tumor cells.
Tsui JC; Lau CP; Cheung AC; Wong KC; Huang L; Tsui SK; Kumta SM
Oncol Rep; 2016 Dec; 36(6):3181-3187. PubMed ID: 27779699
[TBL] [Abstract][Full Text] [Related]
23. A clinicopathological study of giant cell tumor of small bones.
Yanagisawa M; Okada K; Tajino T; Torigoe T; Kawai A; Nishida J
Ups J Med Sci; 2011 Nov; 116(4):265-8. PubMed ID: 21919814
[TBL] [Abstract][Full Text] [Related]
24. Identification of markers of possible prognostic value in 57 giant cell tumors of bone.
Gamberi G; Serra M; Ragazzini P; Magagnoli G; Pazzaglia L; Ponticelli F; Ferrari C; Zanasi M; Bertoni F; Picci P; Benassi MS
Oncol Rep; 2003; 10(2):351-6. PubMed ID: 12579271
[TBL] [Abstract][Full Text] [Related]
25. Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone.
Wojcik J; Rosenberg AE; Bredella MA; Choy E; Hornicek FJ; Nielsen GP; Deshpande V
Am J Surg Pathol; 2016 Jan; 40(1):72-80. PubMed ID: 26414220
[TBL] [Abstract][Full Text] [Related]
26. Expression of ezrin, CD44, and VEGF in giant cell tumor of bone and its significance.
Zhang J; Dong J; Yang Z; Ma X; Zhang J; Li M; Chen Y; Ding Y; Li K; Zhang Z
World J Surg Oncol; 2015 May; 13():168. PubMed ID: 25929323
[TBL] [Abstract][Full Text] [Related]
27. Giant Cell Lesions of the Maxillofacial Skeleton Express RANKL by RNA In Situ Hybridization Regardless of Histologic Pattern.
Stagner AM; Sajed DP; Nielsen GP; Ebb DH; Faquin WC; Chebib I; Rivera MN; Ting DT; Resnick CM; Peacock ZS; Kaban LB; Deshpande V
Am J Surg Pathol; 2019 Jun; 43(6):819-826. PubMed ID: 30998511
[TBL] [Abstract][Full Text] [Related]
28. The prognostic significance of histomorphometry and immunohistochemistry in giant cell tumors of bone.
Fornasier VL; Protzner K; Zhang I; Mason L
Hum Pathol; 1996 Aug; 27(8):754-60. PubMed ID: 8760006
[TBL] [Abstract][Full Text] [Related]
29. Phenotypic and molecular differences between giant-cell tumour of soft tissue and its bone counterpart.
Mancini I; Righi A; Gambarotti M; Picci P; Dei Tos AP; Billings SD; Simi L; Franchi A
Histopathology; 2017 Sep; 71(3):453-460. PubMed ID: 28477388
[TBL] [Abstract][Full Text] [Related]
30. Extended intralesional curettage preferred over resection-arthrodesis for giant cell tumour of the distal radius.
Abuhejleh H; Wunder JS; Ferguson PC; Isler MH; Mottard S; Werier JA; Griffin AM; Turcotte RE
Eur J Orthop Surg Traumatol; 2020 Jan; 30(1):11-17. PubMed ID: 31297594
[TBL] [Abstract][Full Text] [Related]
31. Giant cell rich osteosarcoma revisited-diagnostic criteria and histopathologic patterns, Ki67, CDK4, and MDM2 expression, changes in response to bisphosphonate and denosumab treatment.
Chow LT
Virchows Arch; 2016 Jun; 468(6):741-55. PubMed ID: 27003154
[TBL] [Abstract][Full Text] [Related]
32. P63 expression as a biomarker discriminating giant cell tumor of bone from other giant cell-rich bone lesions.
Shooshtarizadeh T; Rahimi M; Movahedinia S
Pathol Res Pract; 2016 Oct; 212(10):876-879. PubMed ID: 27473669
[TBL] [Abstract][Full Text] [Related]
33. [Characteristic perfusion pattern of osseous giant cell tumor in dynamic contrast-enhanced MRI].
Libicher M; Bernd L; Schenk JP; Mädler U; Grenacher L; Kauffmann GW
Radiologe; 2001 Jul; 41(7):577-82. PubMed ID: 11490778
[TBL] [Abstract][Full Text] [Related]
34. Incidence and demographics of giant cell tumor of bone in The Netherlands: First nationwide Pathology Registry Study.
Verschoor AJ; Bovée JVMG; Mastboom MJL; Sander Dijkstra PD; Van De Sande MAJ; Gelderblom H
Acta Orthop; 2018 Oct; 89(5):570-574. PubMed ID: 29987945
[TBL] [Abstract][Full Text] [Related]
35. p63 as a prognostic marker for giant cell tumor of bone.
Yanagisawa M; Kakizaki H; Okada K; Torigoe T; Kusumi T
Ups J Med Sci; 2013 Mar; 118(1):23-8. PubMed ID: 23033898
[TBL] [Abstract][Full Text] [Related]
36. CCAAT/enhancer binding protein beta is up-regulated in giant cell tumor of bone and regulates RANKL expression.
Ng PK; Tsui SK; Lau CP; Wong CH; Wong WH; Huang L; Kumta SM
J Cell Biochem; 2010 May; 110(2):438-46. PubMed ID: 20225273
[TBL] [Abstract][Full Text] [Related]
37. Characterization of MicroRNA Expression Profiles in Patients with Giant Cell Tumor.
Qin S; He NB; Yan HL; Dong Y
Orthop Surg; 2016 May; 8(2):212-9. PubMed ID: 27384730
[TBL] [Abstract][Full Text] [Related]
38. Serum Levels of NTx and TRACP5b in Giant Cell Tumor of Bone and its Clinical Implications.
Chen J; Younusi A; Cao L; Xu L; Zhou Y; Zhen T; Song X
Clin Lab; 2015; 61(8):1077-81. PubMed ID: 26427154
[TBL] [Abstract][Full Text] [Related]
39. Risk factors for pulmonary metastases from giant cell tumor of bone.
Chan CM; Adler Z; Reith JD; Gibbs CP
J Bone Joint Surg Am; 2015 Mar; 97(5):420-8. PubMed ID: 25740033
[TBL] [Abstract][Full Text] [Related]
40. Gene expression profiling of giant cell tumor of bone reveals downregulation of extracellular matrix components decorin and lumican associated with lung metastasis.
Lieveld M; Bodson E; De Boeck G; Nouman B; Cleton-Jansen AM; Korsching E; Benassi MS; Picci P; Sys G; Poffyn B; Athanasou NA; Hogendoorn PC; Forsyth RG
Virchows Arch; 2014 Dec; 465(6):703-13. PubMed ID: 25304290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
